£14m fundraise approved as Cheshire biotech announces positive preclinical data for potential chronic kidney disease treatment

Redx Pharma will admit £14m new shares to AIM tomorrow as selective DDR1 inhibitor, RXC009, shows positive early signs.

Related Keywords

Redmile ,Leicestershire ,United Kingdom ,Alderley Park ,Borough Of Cheshire East ,Redx Pharma ,Richard Armer , ,Sofinnova Partners ,